Assessment of a prognostic model, PSA metrics and toxicities in metastatic castrate resistant prostate cancer using data from Project Data Sphere (PDS)

BACKGROUND: Prognostic models in metastatic castrate resistant prostate cancer (mCRPC) may have clinical utility. Using data from PDS, we aimed to 1) validate a contemporary prognostic model (Templeton et al., 2014) 2) evaluate prognostic impact of concomitant medications and PSA decrease 3) evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales: Pitcher, Bethany, Khoja, Leila, Hamilton, Robert J., Abdallah, Kald, Pintilie, Melania, Joshua, Anthony M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289419/
https://www.ncbi.nlm.nih.gov/pubmed/28151974
http://dx.doi.org/10.1371/journal.pone.0170544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289419/
https://www.ncbi.nlm.nih.gov/pubmed/28151974
http://dx.doi.org/10.1371/journal.pone.0170544

Ejemplares similares